Hyperaldosteronism
Chapter 4:Endocrine, nutritional and metabolic diseases
ICD-10 E26 is a billable code used to indicate a diagnosis of hyperaldosteronism.
Hyperaldosteronism, also known as primary aldosteronism, is a condition characterized by excessive production of the hormone aldosterone from the adrenal glands. This overproduction leads to increased sodium retention, potassium excretion, and water retention, resulting in hypertension and potential cardiovascular complications. The condition can be classified into primary hyperaldosteronism, often due to adrenal adenomas or bilateral adrenal hyperplasia, and secondary hyperaldosteronism, which is a response to factors such as renal artery stenosis or heart failure. Patients may present with symptoms such as hypertension, muscle weakness, fatigue, and metabolic alkalosis. Diagnosis typically involves measuring plasma aldosterone and renin levels, along with imaging studies to identify adrenal abnormalities. Treatment options include mineralocorticoid receptor antagonists, surgical intervention for adenomas, and management of underlying conditions in secondary cases. Understanding the endocrine pathways and the role of adrenal gland dysfunction is crucial for effective management and coding of this condition.
Detailed hormone level assessments, imaging results, and treatment plans.
Patients presenting with resistant hypertension and electrolyte imbalances.
Ensure clear documentation of the diagnostic workup and treatment response.
Assessment of renal function and electrolyte levels, along with any renal imaging.
Patients with secondary hyperaldosteronism due to renal artery stenosis.
Document the relationship between renal function and aldosterone levels.
Used to confirm diagnosis of hyperaldosteronism.
Document the reason for the test and the results.
Endocrinologists should ensure comprehensive hormone panels are ordered.
Common symptoms include hypertension, muscle weakness, fatigue, and metabolic alkalosis due to electrolyte imbalances.
Diagnosis typically involves measuring plasma aldosterone and renin levels, along with imaging studies to identify adrenal abnormalities.
